Anixa Biosciences
ANIX
ANIX
13 hedge funds and large institutions have $673K invested in Anixa Biosciences in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$68K |
2 |
BFA
2
BlackRock Fund Advisors
San Francisco,
California
|
$12K |
Top Sellers
1 |
1
Morgan Stanley
New York
|
$0 |
2 |
2
First Manhattan
New York
|
$1K |
3 |
BA
3
Bard Associates
Chicago,
Illinois
|
$276K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$22K |
5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$0 |